Evidence map›Paper›PMID 19358273›Full record

ArticleInternational journal of cancer2009

Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells.

Galina Chipitsyna, Qiaoke Gong, Rathai Anandanadesan, Amer Alnajar, Surinder K Batra, Uwe A Wittel, Diane M Cullen, Mohammed P Akhter, David T Denhardt, Charles J Yeo and 1 more

Abstract read
In one paragraph

Article in International journal of cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Role of the parasympathetic nervous system in cancer initiation and progression.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. RAN GTPase and Osteopontin in Pancreatic Cancer.Pancreatic disorders & therapy · 2013
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Galina ChipitsynaDepartment of Surgery, Jefferson Pancreatic, Biliary & related Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Qiaoke Gong
Rathai Anandanadesan
Amer Alnajar
Surinder K Batra
Uwe A Wittel
Diane M Cullen
Mohammed P Akhter
David T Denhardt
Charles J Yeo
Hwyda A Arafat
Thomas Jefferson University · USCreighton University · USNebraska Medical Center · USRutgers, The State University of New Jersey · USUniversity of Nebraska Medical Center · US

Funding

Smoking and pancreatic cancerR01CA133774 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BATRA, SURINDER K. · 2008 to 2012
$1.8M
Nicotine in Pancreatic Cancer: Molecular MechanismsR21CA133753 · NCI · THOMAS JEFFERSON UNIVERSITY · PI ARAFAT, HWYDA A · 2008 to 2009
$396k
NCI NIH HHS 1R21 CA133753-01NCI NIH HHS R01 CA133774NCI NIH HHS R21 CA133753
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with etiological association with cigarette smoking. Nicotine, an important component of cigarettes, exists at high concentrations in the bloodstream of smokers. Osteopontin (OPN) is a secreted phosphoprotein that confers on cancer cells a migratory phenotype and activates signaling pathways that induce cell survival, proliferation, invasion, and metastasis. Here, we investigated the potential molecular basis of nicotine's role in PDA through studying its effect on OPN. Nicotine significantly (p < 0.02) increased OPN mRNA and protein secretion in PDA cells through activation of the OPN gene promoter. The OPN mRNA induction was inhibited by the nicotinic acetylcholine receptor antagonist, mechamylamine. Further, the tyrosine kinase inhibitor genistein inhibited the nicotine-mediated induction of OPN, suggesting that mitogen activated protein kinase signaling mechanism is involved. Nicotine activated the phosphorylation of ERK1/2, but not p38 or c-Jun NH2-terminal MAP kinases. Inhibition of ERK1/2 activation reduced the nicotine-induced OPN synthesis. Rats exposed to cigarette smoke showed a dose-dependent increase in pancreatic OPN that paralleled the rise of pancreatic and plasma nicotine levels. Analysis of cancer tissue from invasive PDA patients, the majority of whom were smokers, showed the presence of significant amounts of OPN in the malignant ducts and the surrounding pancreatic acini. Our data suggest that nicotine may contribute to PDA pathogenesis through upregulation of OPN. They provide the first insight into a nicotine-initiated signal transduction pathway that regulates OPN as a possible tumorigenic mechanism in PDA.

Indexed as

SmokeAnimalsCarcinoma, Pancreatic DuctalCell Line, TumorEnzyme-Linked Immunosorbent AssayExtracellular Signal-Regulated MAP KinasesFemaleGene Expression Regulation, NeoplasticHumansNicotineOsteopontinPancreatic NeoplasmsRatsRats, Sprague-DawleyReverse Transcriptase Polymerase Chain ReactionRNA, MessengerExtracellular Signal-Regulated MAP KinasesNicotineOsteopontinRNA, MessengerSmoke

Identifiers

PMID19358273
PMCPMC4465299
OpenAlexW2059655985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.